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Chirality is ubiquitous in living organisms, as nature has evolved to favor one 
“handedness” over the other. The role of chirality has become firmly established in the 
pharmaceutical industry because of the fact that around 56% of the drugs currently in use 
are chiral compounds and about 88% of these chiral synthetic drugs are racemic mixtures. 
The two enantiomers of a chiral drug may possess different pharmacological activity, 
potency, and mode of action. In addition, a therapeutically inactive enantiomer may 
sometimes show unwanted effects and have antagonistic functions and even toxic effects. 
Therefore, development of pure enantiomer drugs is of immense importance, and kinetic 
resolution of enantiomers from racemic mixtures is a critical element in the commercial 
production of enantiomerically pure chiral compounds. It has been found in the literature 
that cyclodextrins have the ability to recognize and discriminate two enantiomers by 
forming transient inclusion diastereomeric complexes. Hence, our objective here is to 
investigate the mechanisms of the complexation and enantiorecognition of cyclodextrin 
using computational methods and, further, to provide a framework for designing 
cyclodextrin chiral selectors with enhanced binding affinity and chiral selectivity. 
 
In the present work, we study the energetic and conformational preferences involved 
in the chiral discrimination of tryptophan enantiomers by β-cyclodextrin using solvent-
explicit molecular simulations to elucidate chiral recognition mechanisms. The behavior 
of the inclusion compounds formed by β-cyclodextrin and the guest molecule is 
examined through energy minimization and molecular dynamics (MD) simulations. The 
 v
trajectories from the MD simulations are used to obtain the relative weights of the 
different interaction energy components responsible for the discrimination. In addition, 
we also formulate a computational model to simulate a macroscopic separation process 
involving flow of racemic mixture passing through a cyclodextrin-coated membrane. The 
separation occurs because of the differences in the interactions of the two enantiomers 
with the β-cyclodextrin molecules, resulting in different effective mobility.  
 
Our analysis based on MD simulations highlight the differences in the interactions 
between β-cyclodextrin and tryptophan enantiomers. The simulations show that β-
cyclodextrin tends to perform induced-fit structural changes in order to accommodate the 
guest molecules more tightly. The interaction energy calculations for the two 
diastereomeric complexes show that L-tryptophan forms a more stable complex with β-
cyclodextrin. The results from the computational rendition of the membrane separation 
experiment are also consistent with the actual experimental results, which show that β-
cyclodextrin can be used to discriminate and separate the enantiomers of tryptophan. 
However, the energy difference between the pair of diastereomeric complexes is quite 
small and the separation efficiency is not large enough for industrial application. 
Therefore, in addition to native cyclodextrin, we have examined the possibility of using a 
cyclodextrin derivative, heptakis (2-O-Acetylated)-β-cyclodextrin, in place of native β-
cyclodextrin. We find that the enantioselectivity of acetylated cyclodextrin is enhanced 
compared to native cyclodextrin. However, the binding affinity is reversed, i.e. the native 
cyclodextrin prefers binding with L-enantiomer, whereas acetylated cyclodextrin favors 
D-enantiomer.  
 vi
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CHAPTER 1 INTRODUCTION 
 
1.1 General Background on Chirality 
 
Chirality, which is defined as the property of an object not being superimposable with its 
mirror image, is an intrinsic universal feature existing in all levels of matter [1-3]. The 
pair of mirror image objects is called enantiomers, while a mixture containing equal 
amount of each enantiomer is described as racemic mixture or racemate. Common 
notations used to describe enantiomers are L-D and R-S systems. The two enantiomeric 
forms are also known as optical isomers because the study of chirality originated from the 
work of Jean-Baptise Biot in 1815 when he investigated the nature of plane-polarized 
light [4]. As chiral molecules interact with plane-polarized light, one enantiomeric form 
rotates the plane-polarized light to the right while the other to the left; however, the 
racemic mixture is optically-inactive with no effect on the polarized light.   
 
Enantiomers are related to each other as a right hand is to a left hand, and they are a 
result of a tetrahedral carbon bonded to four different substituents [4]. The pair of 
enantiomers displays identical physical and chemical properties, such as boiling and 
freezing point, NMR spectra and IR spectra, in their gaseous, liquid and solid states as 
well as when in solution in all types of non-chiral environment. However, it is only when 
a chiral molecule is subjected to a chiral influence that chirality of the chiral molecule 
can be observed [5]. For instance, the S-enantiomer of carvone smells like caraway, 
whereas the R-enantiomer smells like spearmint. The different smell may be due to our 
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olfactory receptors, which also contain chiral molecules and behave differently in the 
presence of different enantiomers. 
 
1.2 Implication of Chirality and Need for Producing Single 
Enantiomer Drugs 
 
Life is based on chiral molecules [6]. One of the most striking characteristics of life is its 
ability to produce a particular enantiomer instead of a racemate. Biological processes 
almost invariably produce pure stereoisomers. This can be understood from the fact that 
L-amino acids are exclusively used in protein synthesis and sugars used in biological 
bodies are in D-form. As a result, metabolic and regulatory processes mediated by 
biological systems are sensitive to stereochemistry and can give different responses when 
interacting with a pair of enantiomers. As a consequence, the role of chirality has become 
firmly established in the pharmaceutical industry [7], as around 56% of the drugs 
currently in use are chiral compounds and about 88% of these chiral synthetic drugs are 
racemic mixtures [8].  The two enantiomers of chiral drugs may possess different 
pharmacological activity, potency, and mode of action. Besides, the therapeutically 
inactive enantiomer sometimes shows unwanted effects, antagonistic functions and even 
toxic effects [9]. For example, the production of drugs was severely affected by the 
thalidomide tragedy in the early 1960s. Thalidomide was intended as a mild sedative and 
was used widely in Europe to alleviate nausea (morning sickness), which was common 
during that period. However, its inactive enantiomer, which was present in the racemic 
mixture, caused severe birth defects when the drug was taken during pregnancy. 
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Therefore, the development and production of pure active enantiomeric drugs is of 
immense importance.  
 
Besides the therapeutic benefits of single enantiomeric drugs, the economic interests 
also play an important role in driving the development of new chiral substances and 
technological improvements related with the subject. According to the consulting firm 
Technology Catalysts International, the worldwide sales of chiral drugs in single-
enantiomer dosage forms continued growing at more than 13 percent annual rate to US 
$133 billion in 2000, and the figure may hit to $200 billion in 2008 [7]. Furthermore, the 
“racemate-versus-enantiomer” debate is a new market strategy, “the racemic switch”, 
which stands for the development in single-enantiomer form of a drug that was first 
approved as a racemate. A company can get a patent on an individual enantiomer in this 
way [10]. One example is the case of citalopram (Figure 1.1), which is an antidepressant 
medication and is sold and patented as a racemic mixture. However, only the S-
enantiomer has the desired antidepressant effect and hence the pure enantiomer, which 
now is sold under the name of escitalopram, is approved by the US FDA and under the 
Escitalopram Patent. As a result, due to the increasing demand of chiral compounds in the 
pharmaceutical industry, pharmaceutical companies are competing strongly, and chiral 




S-citalopram         R-citalopram 
Figure 1.1 Schematic structures of S- and R-citalopram 
 
1.3 Methods for Chiral Separation 
 
Because of the strong stimulus in the research and production of pure enantiomeric drugs, 
the chiral separation methods and techniques have become widely used in the last two 
decades. There are two general methods to separate two enantiomers from each other in a 
racemic mixture; one is the direct separation method, where the enantiomers are 
separated by crystallization or by using chiral separation phases, and the other is the 
indirect method of separation, where the pair of enantiomers are reacted with another 
pure enantiomeric molecule to become a pair of diastereoisomers, which possess 
sufficiently different chemical and physical properties and hence can be separated easily 
using normal separation techniques. A brief introduction of these different separation 




1.3.1 Direct Chiral Separation 
1.3.1.1 Crystallization 
 
Crystallization is one of the oldest and most fascinating resolution methods. It separates 
enantiomers from the solution of racemic mixture in the absence of resolving agents.  
This is the case of the Pasteur’s discovery of enantiomers. When Pasteur worked on the 
crystallization of a concentrated solution of sodium ammonium tartrate below 28°C, two 
distinct kinds of crystals precipitated, one of “right-handed” crystals and one of “left-
handed” crystals (Figure 1.2). This method of crystallization is still in use today to 
produce some substrates in both small and large scales because it is simple and 
inexpensive compared to other separation techniques. However, it is far from being 
generally applicable since the racemate must be a conglomerate under the conditions of 
crystallization, i.e., the two enantiomers must lead to different crystal structures. 
Unfortunately, the occurrence of conglomerates in nature is not common and represents 
only 5-10% of crystalline racemates [4]. 
 
 
Figure 1.2 Conglomerate crystals of sodium ammonium 
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1.3.1.2 Chiral Separation Phases (CSPs) 
 
In addition to crystallization, direct chiral separation can also be performed by interacting 
enantiomers with a chiral selector, which is also a chiral molecule, using separation 
techniques, such as chromatography, capillary electrophoresis or membrane separators. 
The chiral selectors, sometimes called chiral separation phases (CSPs), form transient 
complexes or diastereomeric pairs with the enantiomers. The different stability of the 
diastereoisomers results in different effective mobility for the two enantiomers in a 
dynamic equilibrium process, and thus the separation of the two enantiomers occurs. For 
that reason, the choice of chiral selectors, which have the ability to recognize and 
discriminate enantiomers, is an indispensable step to achieve direct chiral separation [12]. 
So far, a variety of chiral selectors has been developed for enantiomeric separation. In 
order to provide information on the selection of the separation phases, there has been a 
classification of the basic types of CSPs based on the diastereomeric complexes 




Brush-type CSPs, which are the most widely researched, contain the largest number of 
commercially available products. This type of CSPs is also called “Pirkle CSPs” because 
of the major contribution made by Pirkle and his coworkers [5]. The complex formation 
between the chiral molecule and CSP involves a combination of hydrogen bonding, 
dipole/dipole interactions, π-π interactions and steric hindrance. These interactions fit 
well with the “three-point interaction” theory, which states that in order to recognize the 
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two enantiomers, the selector molecule should interact with the enantiomer molecules at 
a minimum of three points, at least one of those being stereochemically dependent [14-
16]. The graphical representation of a simple “three-point interaction” model is shown in 
Figure 1.3 [13]. The mechanism for the chiral selector to recognize the two enantiomers 
is that the chiral selector interacts with one enantiomer at three active sites but interacts 
with the other enantiomer at only two active sites. Therefore, the two transient complexes 
formed possess different stabilities, and the chiral selector has the ability to recognize and 
discriminate the two enantiomers. Figure 1.4 gives an example of enantioseparation of 
antagonists (metoprolol or bisoprolol) by the an amide derivative of a Pirkle-type CSP 
[17]. The amide CSP interacts with the R-enantiomer with two hydrogen-bonds; whereas, 
the interaction between the S-enantiomer and the amide CSP consists of two hydrogen-
















Figure 1.3 Simple three-point interaction model for stereochemical resolution 
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Figure 1.4 Example of enantio-separation of adrenergic drugs (metoprolol or bisoprolol) 
by amide CSP (A) Interaction between the R-enantiomer and CSP with two 
hydrogen-bonds. (B) Interaction between the S-enantiomer and CSP with two 
hydrogen-bonds and one π-π interaction. 
 
 
These brush-type CSPs have the advantages of facile use, high enantio-selectivity and 
high capacity, but they are only available for enantio-discriminating the compounds 





The polysaccharide-based CSPs contain cellulose-based and amylase-based CSPs as well 
as their derivatives-based CSPs [9].  The structures and the functional groups for these 
CSPs are listed in Figure 1.5, which shows that there are a number of active sites in each 
derivative to interact with the functional groups on the chiral molecules. The type of 
interactions, which contributes to chiral recognition, consists of π-π stacking interactions, 
dipole/dipole interactions, and hydrogen bonding [18, 19]. The polysaccharide-based 
CSPs have the advantage of broad applications to different chiral compounds, such as 
 9
diaminodicarboxylic acid, amino acid as well as their derivatives [20]. Moreover, they 
possess different resolution selectivity due to the different configurations in the glucose 
units and have been proven to be one of the most useful CSPs because of their versatility, 
durability, and in particular, loadability. 
 
    
Cellulose derivatives      Amylose derivatives 
 
R1 










The mechanism of chiral resolution by ligand-exchange CSPs are the formation of 
diastereomeric ternary complexes (Figure 1.6) that consist of a transition metal ion (M), a 
chiral ligand (L) and one enantiomer of the racemic solutes (R or S). Among all of the 
transition metal ions examined [Cu(II), Ni(II), Zn(II), Hg(II), Co(III), Fe(III), etc.], Cu(II) 
forms the most stable complexes with the enantiomers [20].  For selection of the chiral 
ligand, cyclic amino acids such as L-proline and L-hydroxyproline are found to be the 
best chiral selectors to bind with the metal ions. The diastereomeric mixed chelate 
complexes formed are expressed by the formulas L-M-R and L-M-S. Because of the 
different stabilities of these complexes, chiral separation of the racemic mixture occurs. 
Nevertheless, the enantiomers that can be resolved by the ligand-exchange CSP are 
limited to the molecules which are able to form coordination complexes with the 
transition metal ions, such as amino acids, amino acid derivatives, 2-amino alcohols, 
barbiturates and hydantoins [21].  
 
 
Trans-ternary complexation  Cis-ternary complexation 





Protein-based CSPs have attracted special attention because of their special properties of 
stereoselectivity and their ability to separate a wide range of chiral compounds [20]. 
Amino acids are the main building blocks of proteins, and additional sugar moieties are 
found in the glycoproteins. Both the amino acids and sugar moieties are chiral. The 
complexity of protein structures produces very specific binding sites, which often occur 
in enzymes. The hydrophobic forces, electrostatic interactions, and hydrogen bonds are 
proposed to be responsible for protein to bind specifically with one enantiomer of a chiral 
molecule. Due to the disadvantages of low capacity, limited understanding of the chiral 
recognition mechanism and short lifetime, protein-based CSPs are mainly used for 
analytical purposes instead of large-scale industrial application [22]. 
 
Crown Ethers and Cyclodextrin CSPs 
 
This type of chiral separation phases represents a diverse group united by their chiral 
recognition mechanism which is based on the insertion or inclusion of a part of or the 
entire solute molecule into a chiral cavity in the CSP [13]. The different stability of the 
diastereomeric inclusion complexes results in the chiral discrimination of the enantiomers 
of the solute molecule. The typical CSPs in this group contain crown ethers and 
cyclodextrin [20].  
 
Crown ethers are synthetic macrocyclic polyethers; especially 18-crown-6-tetra-
carboxylic acid, whose structure is shown in Figure 1.7, is the most commonly used 
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chiral selector. This chiral cyclic polyether forms a cavity, which is able to include and 
provide enantio-discrimination for alkali and earth-metal ions as well as primary 
ammonium cations [23]. The mechanism for the chiral recognition by this polyether is the 
incorporation of the ammonium ion with the oxygen atoms from the ring system through 
ion-dipole interactions. Additional lateral interactions between the ammonium solute and 
the four carboxylic acids are also necessary [24]. 
 
 
Figure 1.7  The chemical structure of 18-crown-6-tetra-carboxylic acid 
 
Cyclodextrins (CDs) and their derivatives have been used extensively in chiral 
resolution. They are a family of cyclic D-gluco-oligosaccharides produced from starch by 
enzymatic reaction. The chiral glucose units are linked in a α-1→4 chair conformation, 
resulting in a hollow truncated cone [25]. The three kinds of commercially available 
cyclodextrins are α-, β- and γ-CD, consisting of six, seven and eight glucopyranose units 
respectively (Figure 1.8). Because of the conformation of the glucose units, all the 
secondary hydroxyl groups are situated on the wider edge of the ring with all the primary 
hydroxyl groups placed on the other edge. The cavity is lined with carbon atoms as well 
as the glycosidic oxygen bridges. The non-bonding electron pairs of the glycosidic 
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oxygen bridges are directed toward the inside of the cavity resulting in a high electron 
density and some Lewis base characteristics [26].  
 
 
Figure 1.8 Structures of α-, β- and γ-cyclodextrins 
 
The critical properties of cyclodextrins originate from their unique structure, where 
the rims are hydrophilic and the cavity is hydrophobic. The presence of the cavity enables 
cyclodextrins to form inclusion complexes with a range of organic, inorganic, and 
biological molecules via non-covalent interactions in aqueous solution [27]. Chiral 
recognition is observed due to the difference in the stability of the diastereomeric 
complexes formed by cyclodextrin and the two enantiomers [28]. The driving forces for 
the complex formation have been attributed to hydrophobic interactions, van der Waals 
interaction, hydrogen bonding, and release of ring strain in the cyclodextrin cavity [29].  
 
In summary, for direct chiral separation of enantiomers from racemic mixtures, the 
selection of the chiral selector is crucial in order to achieve maximum separation 
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selectivity and efficiency. The different types of chiral selectors, which possess specific 
structural properties, are only effective to the kinds of chiral molecules with certain 
structures. There is no single chiral selector that is effective in separating all chiral 
molecules. Therefore, according to the structure of the enantiomers, we can choose the 
type of chiral selector or even design selectors with specific functional groups to enhance 
the selectivity. 
 
1.3.2 Indirect Chiral Separation 
 
Indirect chiral separation, which is an efficient technique for resolution of many 
enantiomers, is to achieve separation without the presence of a chiral selector. The basis 
of this approach is the irreversible derivatization of the enantiomers (SS and SR) with an 
enantiomerically pure reagent (AS) as shown in Equation 1.1 [30]. The stable products 
(SS·AS and SR·AS) from the reaction are diastereoisomers, which show sufficiently 
different physical and chemical properties, such as freezing point and mobility. Therefore, 
the pair of diastereoisomers can be easily separated in achiral environment by using 
common techniques of crystallization and non-chiral chromatography [31]. After 
separation, the derivatized products are converted back to their original form. Compared 
to the direct separation methods, the indirect separation approach possesses the advantage 
of low cost and versatility. However, this method has a serious drawback in that the 
derivatizing agent (AS) must be enantiomerically pure. Otherwise, if the derivatizing 
agent contains two enantiomers (AS and AR), two pairs of diastereoisomers (SS·AS and 
SR·AR, SR·AS and SS·AR) are generated in the products as shown in Equation 1.2. The two 
pairs of diastereoisomers are enantiomeric to each other and hence are not separable in 
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non-chiral environment. In addition, the nature, availability, costs and ease of cleavage of 
the chiral derivatizing agent sometimes limit the use of this strategy. 
 
          S R S S S R SS S A S A S A+ + → ⋅ + ⋅            (1.1)  
  S R S R S S R S S R R RS S A A S A S A S A S A+ + + → ⋅ + ⋅ + ⋅ + ⋅      (1.2) 
 
 
In conclusion, the importance of chirality in the pharmaceutical industry and the need 
of producing single enantiomer drugs are the driving forces for the development of chiral 
separation methods and technologies. The commonly used methods for resolving 
enantiomers of chiral compounds can be classified into direct and indirect separation. In 
the indirect separation method, the enantiomers are firstly derivatized into a pair of 
diastereoisomers, which can be easily separated. The derivatized form, then, can be 
converted back to the original molecules. For direct separation methods, although 
crystallization is the simplest separation method, it only applies to enantiomers that are 
conglomerate during crystallization. The use of chiral separation phases allows us to 
separate enantiomers of racemic mixtures directly by forming transient complexes, which 
show different stabilities, resulting in different effective mobility in a dynamic process. 
The selection of the separation methods depends on the properties of chiral molecules 
and the feasibility as well as the cost of the separation process. 
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1.4 Motivations and Objectives 
 
In the study, we investigate the chiral recognition mechanism of cyclodextrin. Detailed 
information about cyclodextrin will be given in the following chapter. As already stated, 
a clear understanding of chiral recognition and discrimination mechanisms is important in 
the pharmaceutical industry to further develop enhanced chiral selectors with better 
selectivity and efficiency. Our objective here is to investigate a few key fundamental 
concepts that shed light on the above by employing computational methods. For example, 
the questions that we plan to address include: 
• How do cyclodextrins bind and recognize the two enantiomers? 
• Which of the intermolecular interactions between cyclodextrin and enantiomers is 
responsible for the complexation and the discrimination (e.g. the van der Waals 
forces or Coulomb forces)? 
• Which site of cyclodextrin (primary rim or secondary rim) is primarily 
responsible for binding and enantiorecognition? 
 
Answering these questions will help us to interpret experimental observations, design 
additional needed experiments, and, further, make predictions about the separability of 
enantiomers by using cyclodextrin, the elution order, and the relative magnitude of 
enantioselectivity. Moreover, with a clear understanding of the chiral recognition 
mechanism of cyclodextrins, one can also explore the effects of different substitutional 
groups at the discriminating point of cyclodextrins and the ability of various cyclodextrin 
derivatives to enhance the chiral selectivity. 
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1.5 Structure of Thesis 
 
The thesis consists of seven chapters. First, a general overview about chirality, the 
importance and need for producing single enantiomeric drugs, and the different methods 
for separating enantiomers are presented in Chapter 1. 
 
Historical reviews and current research both of experimental studies as well as 
computational studies in chiral separation using cyclodextrins are described in Chapter 2. 
In addition, a brief discussion of the difficulties that one faces in using cyclodextrin-
based CSPs is given.  
 
Next, Chapter 3 describes the molecular models for the chiral selectors (β-
cyclodextrin) and analyte enantiomers (L/D-tryptophan). A general introduction to the 
computational methodologies (Monte Carlo Method and Molecular Dynamics Simulation) 
that will be implemented in our studies is also given. 
 
Chapter 4 presents the complexation process of the chiral selectors (β-cyclodextrin) 
and analyte enantiomers (L/D-tryptophan) based on Monte Carlo simulations and the 
dynamic process of the complexes in a solvent examined through molecular dynamics 
simulation. From the discussion of the overall interaction energy calculation, formation 
of the hydrogen-bonded network and radial distribution function, it is concluded that L-
tryptophan interacts with β-cyclodextrin more strongly than D-tryptophan.  
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Following the above, a computational model for separating racemic mixtures is 
developed in Chapter 5 in order to mimic real experiments based on membrane-based 
separation. A chiral film consisting of β-cyclodextrin molecules is constructed in silico to 
identify and discriminate enantiomers. The enantiomer that binds with β-cyclodextrin 
more strongly will be transported through the chiral film slower than the other, and, 
therefore, differing levels of displacements of the two enantiomers are observed as a 
function of time. 
 
Chapter 6 describes the advantages of and the challenges faced in modification of 
cyclodextrin. Modifications offer the introduction of new structure and functionality into 
cyclodextrins that are unavailable in the native form so that the binding affinity and chiral 
selectivity towards analyte molecules may be enhanced. However, the challenges facing 
modification are that there are so many hydroxyl groups that the production of single-
isomeric derivative form is difficult. In this chapter, one single-isomeric derivative, 
Heptakis (2-O-Acetylated)-β-cyclodextrin, is studied for investigating the effect of the 
derivatization on chiral selectivity. The results show that this derivatized form of 
cyclodextrin gives better chiral selectivity than native form with reverse pattern of 
binding.  
 
Finally, Chapter 7 presents some concluding remarks based on this work. The 
potential future opportunities in using cyclodextrin are also suggested. 
 19
CHAPTER 2 LITERATURE REVIEWS 
 
2.1 Fundamentals of Cyclodextrins 
 
We have selected cyclodextrins (CDs) in the present work to investigate chiral 
recognition and discrimination phenomena. The critical properties of cyclodextrins, 
which make cyclodextrins important in both research and industrial applications [32], 
originate from their unique structures, where the rims are hydrophilic and the cavity is 
hydrophobic. As shown in Figure 2.1, the primary and secondary hydroxyl groups are 
situated at the narrow and wide rims, respectively, giving them a hydrophilic character, 
while the hydrophobic nature of the cavity is due to the H3 and H5 hydrogen atoms and 
lone pairs of the glucosidic oxygen atoms pointing inside the cavity [32]. The presence of 
the lipophilic cavity enables cyclodextrins to form inclusion complexes with a wide range 
of organic, inorganic, and biological molecules in aqueous solution [27]. The driving 
forces for the complex formation are thought to be hydrophobic interactions, van der 
Waals interaction, hydrogen bonding, and release of ring strain in the cyclodextrin cavity 
[29]. Furthermore, because cyclodextrins are available in enantiomerically pure form and 
exhibit chiral recognition ability by forming diastereomeric inclusion complexes with 
chiral guests, they have found widespread applications in discriminating enantiomers. 
Chiral recognition is observed due to the difference in the stability of the diastereomeric 




           
 
 
Figure 2.1 The schematic representation of (a) glucopyranoside unit and (b) the cyclic 
structure of cyclodextrin. The red digit labels the atom numbering. For α-, β- 
and γ-cyclodextrin, n equals to 6, 7, and 8, respectively. 
 
It has been found that cyclodextrins have the broadest spectra among all the chiral 
selectors which have been applied in chromatographic practices [33]. For cyclodextrin-
based chiral selectors, there are no strict requirements for the structures of analytes in 
order to achieve successful chiral resolution [34]. Even the functionless saturated 
branched aliphatic hydrocarbons, for example, have been successfully separated by 
cyclodextrin-based CSPs in gas chromatography [35]. Moreover, because of the 
numerous hydroxyl groups at both edges of cyclodextrins, it is easy to modify them with 
a variety of substituent groups, such as hydroxypropyl, naphthyl-ethylcarbamoyl, etc., 
and this may enhance complex–forming ability and selectivity towards certain analytes. 
Lastly, cyclodextrins, nowadays, are produced by environmentally friendly technologies 
in large amounts so that their initially high prices (the price of β-cyclodextrin was around 
$2000US/kg in 1970s as a rare fine chemical) have dropped to levels where they become 




Cyclodextrins, in addition to the precious advantages, also possess some severe 
drawbacks. First, their application in separation is due to the property of forming 
inclusion complex with guest molecules; hence it is limited to compounds that can enter 
into the cavity of cyclodextrins. The structures of cyclodextrins are very flexible and the 
complexation process with guest molecules is quite complicated [36]. Even small 
changes in analyte structure often lead to unpredictable effects upon resolution. Lastly, 
the separation efficiency of cyclodextrins is poor, with selectivity rarely exceeding two.  
 
2.2 Experimental Studies 
 
The chiral–recognition ability of cyclodextrin by forming inclusion complexes with 
enantiomers was discovered by Gramber in 1950s [37]. Cyclodextrins were first 
introduced as chiral selectors in gas chromatography in 1980s and rapidly became the 
most powerful and versatile materials for enantioseparation. Capillary electrophoresis 
(CE), gas chromatography (GC) and liquid chromatography (LC) are the major 
techniques used for cyclodextrin-based chiral separation. In 1985, Armstrong and co-
workers [38] first reported the successful separation of 13 enantiomeric pairs of 
metallocene compounds using β-cyclodextrins bonded phase in liquid chromatography. 
In the late 1980s, cyclodextrins have been employed in enantioselective capillary 
electromigration methods, and Guttman et al. [39] published the first enantioseparation in 
capillary gel electrophoresis.  
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Since 1994, capillary electrophoresis has received the most attention for chiral 
resolution based on cyclodextrins and dominates the publications in literature in this field. 
The reason for the sharp increase in interest in capillary electrophoresis is that 
cyclodextrins and their derivatives usually show moderate chiral selectivity, with the 
selectivity values α rarely exceeding 2. The use of capillary columns results in high 
efficiency, which compensates for the moderate selectivity of cyclodextrins. On the other 
hand, liquid and gas chromatographic methods have limited efficiency, and thus they 
require chiral selectors with high selectivity, such as protein-based CSPs [33]. 
 
Although chromatographic and capillary electrophoresis technologies can be used to 
produce enantimerically pure substances in both analytical and preparative scales, they 
have a main drawback in that they can only be operated in batch processes. Instead, 
membrane technologies for chiral resolution have recently attracted much attention 
because they can be operated as continuous processes for commercial-scale preparation 
of single enantiomer products [40]. Xiao et al. [41] have already reported the resolution 
of racemic tryptophan solutions by membrane-based system using β-cyclodextrins. 
 
So far, a remarkable number of new cyclodextrin-based chiral selectors have been 
developed, and a current trend is to synthesize single isomer cyclodextrin derivatives for 
enhancing selectivity and reproducibility. For example, 6-O-Succinyl-β-cyclodextrin 
(CDsuc6) was developed by Cucinotta et al. [42] and successfully applied to the chiral 
resolution of norephedrine, epinephrine, terbutaline, and norphenylephrine. Compared to 
randomly succinylated β-cyclodextrin, this reagent showed improved resolution. The 
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group of Vigh recently developed single isomer cyclodextrin derivatives with negative 
charges are: hexakis(2,3- diacetyl-6-O-sulfo)-α-cyclodextrin [43], hexakis(2,3-di-O-
methyl-6-O-sulfo)-α-cyclodextrin [44], hexakis(6-O-sulfo)-α-cyclodextrin [45], the 
tetrabutylammonium salt of heptakis(2,3-Odiacetyl-6-O-sulfo)-β-cyclodextrin, which was 
used in nonaqueous medium [46], heptakis(2-O-methyl-6-O-sulfo)-β-cyclodextrin, 
heptakis(2-O-methyl-3-O-acetyl-6-O-sulfo)-β-cyclodextrin, the latter two derivatives 
carrying nonidentical substituents at all of the C2, C3, and C6 positions [47]. The 
selectors found application in the chiral separation of a great variety of drugs.  
 
2.3 Computational Studies 
 
Along with the dramatical increase in experimental studies of chiral separation by 
cyclodextrins, a number of computational studies directed towards understanding the 
chiral recognition have been reported. The biggest obstacle in the computational studies 
is that the enantiodiscriminating forces are usually very small compared to the 
complexing forces between cyclodextrins and chiral analytes, typically by 2-3 orders of 
magnitude. Hence, the challenge is to compute very small energy differences, often less 
than 500 cal/mol, between the two diastereomeric pairs [48].  
 
One commonly used approach is the so called double–difference method, first used 
successfully by DeTar [49] to computationally evaluate enzyme-substrate specificity. In 
this approach, differential free energies are calculated instead of absolute free energies. 
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For example, Equation 2.1 and Equation 2.2 represent two competing equilibria that exist 
in all systems where enantioselective binding takes place.  
 
Equilibrium 1 R R R RH G H G+ ⋅   (2.1) 
Equilibrium 2 R S R SH G H G+ ⋅   (2.2) 
 
Here, H and G stand for the host and guest molecules, respectively. The superscripts 
R and S are the stereochemical descriptors. In both equilibria, the binary complexes are 
often weakly bound by van der Waals forces, coulomb forces, hydrogen bonding, and so 
on. The free energy differences, ΔG, are calculated for both equilibrium 1 and 2. The 
difference between the two free energy differences, ΔΔG, indicates which substrate is 
more tightly bound to the host molecule. In addition, the left-hand sides of the two 
equilibria are the same, both of which contain the same host molecule and one 
enantiomer. The two enantiomers, (R)-guest and (S)-guest, have the same shapes, 
energies as well as the extent of salvation in the unbounded state. Therefore, all one 
needs is to calculate the free energies of the diastereomeric complexes from the right 
hand side of the euqilibria [50]. 
 
Armstrong and co-workers [51] used molecular graphics to represent how β-
cyclodextrin separates enantiomers. The authors treated cyclodextrin as a rigid body and 
allowed only the torsion angles and the location of the analyte in the macrocycle to 
change. They highlighted the importance of the secondary and tertiary hydroxyl groups 
along the wider rim of the macrocycle as being responsible for the resolution of 
enantiomers. This study allowed the authors to rationally design derivatives of CDs to 
optimize a particular separation. 
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Instead of using a rigid–body approach, which was not suitable for cyclodextrin 
molecules because they are very flexible and prone to induced-fit structural changes 
while forming inclusion complexes with analytes, Lipkowitz [52] carried out molecular 
dynamics simulations, which accounted for the flexibility of cyclodextrins, to calculate 
enantioselective binding of tryptophan by α-cyclodextrin. Comparing the computed 
differential binding energies of the two diastereoisomers, the author concluded that the 
R–enantiomer is more tightly bound to α-cyclodextrin than the S–enantiomer; moreover, 
the torsional strain and nonbonded interactions are seen to be the main contributions for 
the chiral discrimination. The same methodologies were also used by Lipkowitz to study 
chiral discrimination properties of β-cyclodextrin [53] and permethylated β-cyclodextrin 
[54-56]. 
 
Adeagbo [28] investigated the degree of chiral discrimination of β-cyclodextrin by 
first minimizing the energy of the complexes formed by analyte and β-cyclodextrin in 
vacuo in order to get initial information about how the complexes formed. The optimized 
complex was solvated in water and followed by molecular dynamic simulation. The 
chiral recognition of β-cyclodextrin was observed by comparing the conformational 
average binding energy differences (0.03 eV) between the two diastereomeric complexes. 
The structural behavior of both enantiomers in the hydrophobic cavity of β-cyclodextrin 
was analyzed through radial distribution functions, which showed that β-cyclodextrin 
bound more favorably to one enantiomer than to the other. 
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2.4 What Remains Unsolved 
 
Because of the great variety of intrinsic chiral centers (due to the chirality of the glucose 
units) and the induced-fit structural change mechanism (due to the flexible structure) of 
cyclodextrins, cyclodextrins can interact with certain analytes in more than one mode of 
interaction arrangements. This multimodal characteristic of cyclodextrins makes it 
difficult for one to predict the success of separations of analytes based on structural 
considerations [57]. Furthermore, due to the moderate selectivity of native cyclodextrins, 
various derivatives which can enhance the selectivity toward certain analytes are used 
more frequently in most of the experimental practices. The substituted derivatives, 
however, are not homogenous; instead, they consist of a larger number of isomers, which 
differ in degree of substitution as well as position of substitution. Almost every isomer 
has different chiral recognition abilities, and even the retention order of enantiomers can 
be reversed by using different degree of substitution rate of sulfated- β-cyclodextrin [58]. 
Therefore, a significant trend now is the introduction and application of single-isomer 
cyclodextrin derivatives [42]. However, investigation of the chiral recognition ability of 
every single-isomer derivatives is quite tedious and time-consuming if one has to rely 
purely on experimental methods. These considerations motivate our computational study 
presented in this work. 
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CHAPTER 3 SIMULATION METHODOLOGY 
 
3.1 Molecular Models for β-Cyclodextrin and Tryptophan 
 
We address here the chiral recognition mechanism of native β-cyclodextrin, which is the 
most frequently used molecule among the three kinds of commercially available 
cyclodextrins, α-, β-, and γ-cyclodextrin, since the cavity size of β-cyclodextrin is 
suitable for accommodating a wide range of analyte molecules and since the cost is low 
for large–scale industrial application. The chiral analyte molecules under investigation 
are tryptophan enantiomers (L/D-tryptophan). L-tryptophan is one of the eight essential 
amino acids in mammals and is the precursor to serotonin, which is thought to be 
important in the modulation of mood and psychology of an individual [59]. The size and 
shape of tryptophan are compatible with the cavity of β-cyclodextrin and, further, 
tryptophan has been reported to be successfully separated by β-cyclodextrin [41].  
 
We use a modified version of the GROMOS96 (43a1) force field, which treats each 
aliphatic carbon atom together with its attached hydrogen atoms as a single interaction 
site [60]. The original structure of β-cyclodextrin is taken from 3CGT.pdb from the 
RCSB Protein Data Bank, the graphical representation of β-cyclodextrin and L/D-
tryptophan shown in Figure 3.1. For water, the extended simple-point-charge (SPC/E) 
model is used, which represents the diffusivity and density of water close to the 




                
 
Figure 3.1 Graphical representations of β-cyclodextrin, (a) D-tryptophan, and (b) L-
tryptophan zwitterion molecules. Labels: Red – Oxygen; Cyan – Carbon; 
Blue – Nitrogen; White – Hydrogen 
 
3.2 Simulation Methodology 
 
3.2.1 Monte Carlo Simulations 
 
Monte Carlo (MC) simulation is a stochastic method to generate a set of representative 
configurations at given conditions (statistical ensembles) such as temperature, volume, 
pressure, or chemical potential. One starts with a collection of particles and computes the 
(a) (b) 
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system’s energy, represented as 1E , for that initial configuration. One or more of the 
particles is then randomly selected and moved to create a second configuration. The 
energy of this configuration, represented as 2E , is computed, and that new configuration 
is deemed “acceptable” in two situations. One is 2 1E E< , which indicates that the new 
configuration is more energetically favorable, the other one is 2 1E E>  with some 
probability of 1 2exp[( ) / ]p E E kT= − . A large number of random moves are made, and a 
large number of energetically acceptable states are thus obtained, providing averaged 
energies or averaged properties of the system being studied.  
 
One attractive aspects of the conventional MC simulation is that only the potential 
energy rather than force is normally evaluated in sampling configurations, leading to very 
efficient calculations although some biased MC methods do need evaluation of force. 
Moreover, MC can perform physically unnatural motions, e.g., a jump from one position 
to the other or insertion/deletion of a new molecule. In its simplest form, MC simulation 
is a method for numerical integration in mathematics. A set of parameters are randomly 
selected, or randomly perturbed, and a function of these parameters is evaluated. 
Depending on the system of interest, various types of trial moves are attempted to bring 
the system to equilibrium. Subsequently, statistically averaged properties can be obtained. 
 
3.2.2 Molecular Dynamics Simulations 
 
Molecular Dynamics (MD) simulation was first used in the 1950’s to simulate simple 
fluids. Since late 1970’s, MD has been gradually employed for biomolecular systems. 
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Now software packages are widely used. Among these, the most popular include Amber 
(Assisted Model Building with Energy Refinement, CHARMM (Chemistry at HARvard 
Macromolecular Mechanics), Gromos (GROningen MOlecular Simulation) and Gromacs 
(GROningen Machine for Chemical Simulations). 
 
Classical MD algorithm is based on the deterministic Newton’s equation of motion 
for a system with N interacting particles, 
2
2
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Where ( )iF t , ( )ia t  and ( )ir t  are the force, acceleration and position of atom i  at time t . 
The force is the negative derivative of the configurational potential function 






              (3.2) 
These equations are solved numerically using a small time step, usually in femtosecond 
timescales. With these ingredients a “trajectory”, which is simply a history of the motion 
of the system over the time period of interest, can be generated and provide information 
concerning the twisting and flexing of rotatable bonds so that dynamical information can 
be obtained. Therefore, MD methods simulate the movement of atoms for a given time 
period and from that one can determine ensemble averages that allow one to make the 
connection between the micro- and macroscopic worlds. 
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CHAPTER 4 INTERACTION ENERGY CALCULATIONS 
FOR THE INCLUSION COMPLEXES 
 
4.1 Complexation of β-Cyclodextrin and Tryptophan 
 
As already stated, β-cyclodextrin is able to form an inclusion complex with guest 
molecule by accommodating the guest molecule into its cavity, and the chiral 
discrimination ability of β-cyclodextrin is due the different stabilities of the two inclusion 
complexes formed with two enantiomers. Hence, in order to identify the possible binding 
site where the complexation occurs between (L- or D-) tryptophan and β-cyclodextrin, 
stochastic annealing was performed using Monte Carlo (MC) method. In the MC 
simulations, the (L- or D-) tryptophan molecule was translated and rotated around the β-
cyclodextrin molecule with both the molecules treated as rigid bodies. During the 
calculation of the intermolecular interaction energy between the host and guest molecules, 
only the non-bonded interactions, which consist of Lennard-Jones (LJ) interaction 
(Equation 4.1) and Coulomb interaction (Equation 4.2), were considered. The charges of 
the atoms and the Lennard-Jones parameters were from the force field, a modified 
version of the GROMOS96 (43a1), which treats each aliphatic carbon atom together with 
their attached hydrogen atoms as a single interaction site [60] as already noted in 
previous chapter. The complexes were simulated in an implicit-solvent model with a 





















rπε ε=  (4.2) 
 
The structures of the L-/D-tryptophan-cyclodextrin complexes obtained are shown in 
Figures 4.1 and 4.2. The interaction energy of the D-complex, formed by D-tryptophan 
and β-cyclodextrin, is found to be –104.5 kJ/mol, whereas the interaction energy for L-
complex (L-tryptophan and β-cyclodextrin) is –108.9 kJ/mol. For both the L- and D-
complexes, the enantiomers are encapsulated inside the lipophilic cavity of β- 
cyclodextrin from the secondary hydroxyl rim at almost the same position. From this 
energy minimization step, it is found that L-tryptophan is bound to β-cyclodextrin more 




Figure 4.1 Complex structures of D-tryptophan and β-cyclodextrin from MC simulation. 







Figure 4.2 Complex structures of L-tryptophan and β-cyclodextrin from MC simulation. 
(a) side view (b) top view. 
 
4.2 Binding Energy Calculations  
 
Because the structure of β-cyclodextrin is very flexible, it is prone to induced-fit 
structural changes when it encapsulates guest molecules into its cavity. We resort to 
molecular dynamic simulations in order to take account of the flexibility of β-
cyclodextrin. First, after the binding site was approximately estimated by MC simulation, 
the system was subjected to molecular dynamic simulations. The inclusion complex 
obtained from the MC simulations was solvated in a simulation box containing water. 
Periodic boundary conditions were applied in all the three directions. A cubic box with a 
length of 3 nm was used, containing one host, one guest molecule, and 835 water 
molecules, corresponding to a density of 1 g/cm3 at ambient temperature (300 K). The 
box size chosen was large enough to avoid any interactions between a molecule and its 
periodic images. Gromacs v.3.3.1 simulation package was used to perform MD 
simulations. The Lennard-Jones interactions were calculated with a spherical cutoff 
distance of 1.4 nm. The particle-mesh-Ewald (PME) method [62, 63] was applied to 
(a) (b) 
 34
calculate the Coulomb interactions, with a grid spacing of 0.12 nm and a fourth-order 
interpolation. The water molecules were represented by the extended simple point charge 
(SPC/E) model [61], which represents the diffusivity and density of water closer to the 
experimental values reported in the literature at ambient conditions.  A typical simulation 
box is shown in Figure 4.3. 
 
Figure 4.3 Sample simulation box for the D-complex (D-tryptophan and β-CD) solution 
with 835 water molecules. 
 
For this system, we started with energy minimization by using the steepest descent 
method with a maximum energy criterion of 1.0 kJ/mol, which means that the 
minimization is taken to have converged when the maximum energy is lower than that 
value. The solvent (water) was first energy–minimized with a harmonic position restraint 
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(PR) of 1000 2/( )kJ mol nm⋅  exerted on the heavy atoms of β-CD and tryptophan 
molecules, followed by the energy minimization of the whole system. Following this, the 
system was assigned initial velocities dictated by the Maxwell-Boltzmann distribution at 
300 K. The equilibrium molecular dynamic simulations were performed in a canonical 
(NVT) ensemble with three steps. Firstly, the system was simulated for 500 ps with 1000 
2/( )kJ mol nm⋅ PR exerted on the heavy atoms of β-CD and tryptophan molecules so that 
the inclusion complex can be fully solvated by water molecules. Consequently, another 
simulation was performed for 500 ps with the magnitude of the PR reduced to10 
2/( )kJ mol nm⋅  in order to allow slow relaxation of the whole complex. Finally, the 
whole system was equilibrated for 2 ns, and the production simulation was continued for 
18 ns. For all molecular dynamic simulations, the integration time step was 2 fs, and the 
temperature was controlled by a Berendsen thermostat with a relaxation time of 0.1 ps. 
The neighbor list and long-range forces were updated every 10 steps (0.02 ps).  
 
4.2.1 Evolution of the Inclusion Complex 
 
After the initial configuration of the complexes obtained from the MC is solvated in 
water, an 18 ns equilibrium molecular dynamics simulation is performed to take into 
account the flexibility of the molecules and the effect of solvent. Some snapshots of the 
equilibrium conformation of the D-complex and L-complex during the simulation are 
shown in Figure 4.4. Both tryptophan enantiomers still remain inside of the cavity 
forming stable inclusion complexes, and the structure of β-cyclodextrin, which is very 




Figure 4.4 Snapshots of equilibrium conformations of D-complex (a) and L-complex (b) 
in water solvent during the MD simulation. (The water molecules are not 
shown in the pictures.) 
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4.2.2 Interaction Energy of the Inclusion Complex 
 
The interacting energy upon complexation is one measure of the stability of the inclusion 
complexes formed by enantiomers and β-cyclodextrin. We define the interaction energy 
calculated as the difference between the potential energy of the complex and the potential 
energy of individual molecules as shown in Equation 4.3:  
 
    binding complex TRP= − −E E E Eβ-CD                 (4.3) 
 
The magnitude of the energy change is a sign of the driving force for complexation; that 
is, the more negative the interaction energy is, the more thermodynamically favorable the 
formation of the inclusion complex. The average interaction energies are −106.1 kJ/mol 
and −109.7 kJ/mol for the D-complex and L-complex, respectively. The negative signs of 
the two interaction energies indicate that the formation of the inclusion complexes by 
tryptophan enantiomers and β-cyclodextrin is thermodynamically favorable. Moreover, 
the interaction energy for the L-complex was 3.6 kJ/mol lower compared to that for the 
D-complex, i.e., β-cyclodextrin interacts more favorably with the L-enantiomer than with 
the D-enantiomer.  
 
In order to investigate which forces mainly contributes to the chiral recognition and 
discrimination, the different components of the intermolecular interactions, which 
consisted of the short-range and long-range Lennard-Jones (LJ) interactions as well as the 
Coulomb interaction, were analyzed. As shown in Table 4.1, despite of the small 
difference in long-range Lennard-Jones and Coulomb interactions between the two 
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complexes, the short-range Lennard-Jones interaction plays a major role in the complex 
formation as well as chiral discrimination. This conclusion is also consistent with the 
study of Lipkowitz et al. [53] that the short-range dispersion forces, rather than the 
Coulomb interactions, were responsible for both complexation and enantiodiscrimination. 
 
Table 4.1 Binding energies between L-/D-tryptophan and β-CD from the long-range (LR) 
and short-range (SR) Lennard-Jones (LJ) interactions as well as the Coulomb 
interactions. The short-range LJ interaction is the major contribution to 
complex formation and chiral discrimination. 
 
(kJ/mol) LJ-(SR) LJ-(LR) Coulomb Interaction Energy 
D-Complex – 94.53 – 0.26 – 11.33 – 106.13 
L-Complex – 97.54 – 0.20 – 11.98 – 109.72 
 
4.2.3 Formation of Hydrogen-Bonded Network 
 
As well–known, β-cyclodextrin consists of many hydroxyl groups, which can form 
hydrogen bonds among themselves as well as with the guest molecule. The formation of 
hydrogen bonds between molecules can be determined using geometric and energy 
criteria [64]. In our calculations, we adopt the geometric criterion because it best suits the 
description of hydrogen bonds at a variety of thermodynamic conditions [65]. The 
distance between the donor and the acceptor is less than or equal to 0.35 nm, and the 
hydrogen-donor-acceptor angle is no more than 30º [66]. Table 4.2 gives the number of 
hydrogen bonds between β-cyclodextrin and the tryptophan enantiomer for both the 
complexes. The average number of hydrogen bonds formed between β-cyclodextrin and 
D-tryptophan (D-complex) during the equilibrium simulation is 0.59 compared to 0.63 
for β-cyclodextrin and L-tryptophan (L-complex). The number of time frames with two 
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or three hydrogen bonds formed simultaneously does not differ much for the D- and L-
complexes, as shown in Column 3 and 4, respectively, in Table 4.2. However, for the L-
complex, the number of time-frames with only one hydrogen bond is substantially more 
than that for the D-complex (a difference of 101). As a result, L-tryptophan seems to 
interact with β-cyclodextrin more frequently. 
 
Table 4.2 The number of hydrogen bonds (HB) between β-CD and the tryptophan 
enantiomer for both L- and D- complex during the equilibrium simulation. 
“Single HB” represents the number of time frames where only one hydrogen 
bond is formed.  “Two HB” and “Three HB” represent the number of time 
frames where there are two and three hydrogen bonds formed simultaneously. 
 
Number of 
H-bonds Average Single HB Two HB Three HB 
D-complex 0.59 605 182 26 
L-complex 0.63 706 184 18 
  
4.2.4 Radial Distribution Function Analysis 
 
The radial distribution function (RDF) describes the probability of finding appropriate 
atom pairs as a function of their mutual distance of separation at equilibrium. Here, we 
use it to characterize how the β-CD atoms interact with the enantiomer atoms. The RDF 
between the hydrogen atoms from the secondary hydroxyl groups and oxygen atoms from 
the tryptophan molecule is shown in Figure 4.5. The higher possibility of finding oxygen 
atoms from L-tryptophan around the hydrogen atoms from β-CD appears to be the reason 
for the larger number of hydrogen bonds between L-tryptophan and β-CD and for the 
lower interaction energy for the L-complex. Fig. 6 (a) shows the RDF between the 
oxygen atoms from the secondary hydroxyl group on β-CD molecule and the hydrogen 
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atoms from the amino group on tryptophan molecule. There are two peaks for the D-
tryptophan; one is around 0.32 nm with the other around 0.64nm. The first peak occurs at 
a distance that is within the range of a hydrogen bond. D-tryptophan seems to interact 
with the C2 hydroxyl group on β-CD more strongly. Figure 4.6 (b) shows the RDF 
between the oxygen atoms from the tertiary hydroxyl group on β-CD molecule (Figure 
2.1) and the hydrogen atoms from the amino group on tryptophan molecule. In contrast to 
Figure 4.6 (a), L-tryptophan interacts more favorably with the C3 hydroxyl group on β-
CD. Using such information, we can further improve the selectivity of β-CD towards 
tryptophan enantiomers by specifically derivatizing the hydroxyl groups with suitable 
substituents. 
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Figure 4.5 Radial distribution function for the hydrogen atoms from the β-CD secondary 
hydroxyl groups (H(BCD)) relative to the oxygen atoms from the tryptophan 
molecules (O(trp)). L-tryptophan interacts with β-CD with higher probability 




   
Figure 4.6 (a) RDF for the oxygen atoms from the β-CD C2 hydroxyl group (O2(BCD)) 
relative to the hydrogen atoms from the tryptophan amino group(HN(trp)), 
(b) RDF for the oxygen atom from the β-CD C3 hydroxyl group (O3(BCD)) 
relative to the hydrogen atoms from the tryptophan amino group(HN(trp)). 
 
4.3 Summary  
 
In summary, we use the initial information about the formation of the inclusion complex 
by β-cyclodextrin and tryptophan gained from Monte Carlo simulation, to study the 
dynamic process of the complex in solvent as a function of time using molecular 
dynamics simulation. From the discussion of the overall interaction energy calculation, 
formation of the hydrogen-bonded network and radial distribution function, it is 
concluded that L-tryptophan interacts with β-cyclodextrin more strongly than D-
tryptophan. Moreover, short-range Lennard-Jones interactions play a major role in both 
the complex formation and chiral discrimination. Hence, it is possible to increase the 
enantioselectivity by enhancing Coulomb interactions using charged cyclodextrin 
derivatives to separate oppositely charged analyte enantiomers. In addition, the secondary 
(a) (b) 
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rim of β-cyclodextrin is more responsible for the enantiorecognition, and tryptophan 
enantiomers interact differently with C2 or C3 positioned hydroxyl groups of β-
cyclodextrin. Therefore, derivatizing β-cyclodextrin at C2 or C3 position may enhance 





CHAPTER 5 MEMBRANE-BASED SEPARATION 
 
5.1 Experiment Using Cyclodextrin-Functionalized Membranes 
 
In this chapter, we develop a molecular model for the experiment of Xiao and Chung [41], 
who use a the membrane-based separation system for direct chiral resolution (Figure 5.1). 
Native β-cyclodextrin is grafted on the surface of membrane, forming a chiral layer. The 
feed solution, which contains the tryptophan racemic mixture, passes through the 
cyclodextrin-functionalized membrane under the trans-membrane pressure gradient. 
Because of the chiral recognition ability of β-cyclodextrin, β-cyclodextrin molecules will 
encapsulate tryptophan enantiomers in their cavities forming pairs of transient 
diastereomeric complexes, which possess different stabilities, resulting in different 
effective mobility of the two enantiomers transporting through the membrane. Therefore, 
the enantiomer which is less favorably bound to β-cyclodextrin will be found in higher 









Figure 5.1 A proposed model for chiral separation in membrane-based system. 
Cyclodextrin molecules are grafted on the membrane surface, forming a 
chiral layer. When the racemic feed solution is passed through the chiral 
layer, the enantiomer which binds less favorably with cyclodextrin will be 
found at a higher concentration in the strip solution. 
 
Because the unfunctionalized membrane is not enantioselective towards the 
enantiomers, but only gives mechanical support for the β-cyclodextrin chiral selectors, 
we simplify our model by omitting the membrane and only considering a chiral layer 
consisting of β-cyclodextrin molecules. Therefore, a β-cyclodextrin film is constructed to 
mimic a cyclodextrin-immobilized membrane surface and is then used for separating the 
L/D-tryptophan aqueous racemic mixture. Initially, a tryptophan racemic mixture was 
generated using 9 L-tryptophan, 9 D-tryptophan molecules and 4597 water molecules in a 
4×6×6 (nm3) box (corresponding to a tryptophan concentration of 0.208 M). The 
tryptophan solution was simulated in a canonical (NVT) ensemble for 2 ns in order to get 
a homogeneous solution. Thereafter, a β-cyclodextrin film, which consists of 4 β-
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cyclodextrin in the area of 6×6 (nm2), was added to the tryptophan solution. The final 
simulation model is shown in Figure 5.2. The β-cyclodextrin film was position restrained 
in the axial direction similar to the experiment, where β-cyclodextrin was supported by 
membrane. The flow was achieved by assigning an acceleration to the water molecules, 
which is analogous to the experimental process of exerting pressure by pump to maintain 
the pressure difference between the feed solution and the strip solution. The tryptophan 
molecules thus “flow” with the solvent to pass through the β-cyclodextrin film, thereby  








Figure 5.2 Molecular simulation model for the separation of tryptophan racemic mixture 
by a β-cyclodextrin film (within the dotted lines), which consists of 4 β-
cyclodextrin molecules in an area of 6×6 (nm2). D-tryptophan and L-tryptophan 
are in blue and red, respectively. (a) Side view; (b) Top view. 
 
5.2 Results and Discussion 
 
As mentioned above, a molecular simulation study is presented for the chiral separation 
of L/D-tryptophan aqueous mixture by β-cyclodextrin film (Figure 5.2) in order to 
demonstrate the macroscopic separation process on realistic systems with the 
implementation of periodic boundary conditions. The different time-cales for relevant 
molecular motions and macroscopic processes are a major obstacle for molecular 
simulations [67] because a molecule may undergo many excursions before there is a 
noticeable change in the molecule’s position in the bulk phase. However, due to the weak 
(b) 
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coupling between the (flow induced) translational motion of the molecules and the 
(thermal) random displacements, the flow speed in the simulations can be set at a higher 
value than what is used in a laboratory. The molecular interactions between the chiral 
molecules and selectors are not disrupted during the MD simulation since the average 
translational speed of the liquid phase is still much smaller than the molecular motion. 
 
In the present work, the concentration of the racemic tryptophan solution is 0.208 M, 
as already noted. The self-diffusion coefficients for the L- and D-tryptophan and water 
molecules are calculated and compared with the literature results shown in Table 5.1. 
Both enantiomers have almost the same diffusivity in the solution. During the separation 
process, the flow is achieved by assigning an acceleration of 0.005nm/ps2 to the water 
molecules with a flow velocity of 15m/s. The tryptophan molecules are carried by the 
solvent to move in the axial direction and pass through the β-cyclodextrin layer. The 
average translational motion for the two enantiomers is calculated for 6 ns as shown in 
Figure 5.3. Our result, which shows that D-tryptophan was transported more rapidly than 
L-tryptophan, is consistent with the experimental measurements [41] and our binding 
energy discussion in Chapter 4. Because the tryptophan enantiomers possess the same 
self-diffusivity, if there is no β-cyclodextrin film at the center of the simulation box, both 
the L- and D-tryptophan will be transported at the same velocity. Hence, it is clear that 
the β-cyclodextrin molecule acts as a chiral selector to give different effective mobilities 
to the tryptophan enantiomers and to cause different displacements as simulation time. 
The separation efficiency, which is proportional to the average slope of the movements of 
enantiomers, is around 1.1, comparable to the experimental result of 1.0. The low 
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separation efficiency is consistent with the small binding energy difference calculated 
between the two diastereomeric inclusion complexes (L-complex and D-complex) in 
Chapter 4.  
 
Table 5.1 Self-diffusion coefficients for tryptophan enantiomers and water molecules. 
 
 Diffusivity 
 (×105 cm2/s) (×105 cm2/s) 
 Simulation Experiment 
L-tryptophan 0.69 (±0.04) 0.66*  
D-tryptophan 0.64 (±0.08)  
Solvent 2.54 (±0.03) 2.30# 
 
* Turhan, M., et al., Biotechnology Techniques, 1995. 9(6): p. 413-416. 
# Voth G.A., et al., Journal of Chemical Physics, 2006. 124(2). 
 
Time (ns)




















Figure 5.3 Displacement of L-tryptophan and D-tryptophan as a function of time. D-
tryptophan is transported more rapidly than L-tryptophan with the 
enantioselectivity of about 1.1. 
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5.3 Summary  
 
A computational model for separating racemic mixtures is developed to mimic a real 
experiment based on a membrane-based separation system in which the chiral selector, β-
cyclodextrin is grafted on the membrane surface and acts as a chiral film to discriminate 
enantiomers. The molecules of β-cyclodextrin bind the two enantiomers with different 
stability, which results in different effective mobilities of the enantiomers and different 
displacements with time. The enantiomer that binds to β-cyclodextrin more strongly will 
be transported through the chiral film slower than the other. Furthermore, because of the 
low chiral selectivity of β-cyclodextrin, the separation efficiency we get is also quite 
small (about 1.1), which is consistent with the experimental value of 1.0 reported by Xiao 





CHAPTER 6 ENHANCED CHIRAL SEPARATION 
USING MODIFIED CYCLODEXTRINS 
 
6.1 Modification of Cyclodextrin 
 
As already stated, the chiral selectivity of native β-cyclodextrin is quite limited, and its 
low solubility in aqueous solution also affects its application and performance in 
Capillary Electrophoresis, which is one of the most used techniques for chiral separation 
as analytical purposes, so numerous β-cyclodextrin derivatives have been synthesized by 
replacing the hydroxyl groups with various substitutes for the purpose of increasing 
solubility as well as enantioselectivity. The modification of cyclodextrin offers both 
enormous opportunities and challenges. The opportunities of such modification include 
the increased solubility of β-cyclodextrin through the substitution of the hydroxyl group 
with more hydrophilic groups, such as amino acids and carboxylic groups. The 
modification also provides introduction of new sites for π−π, dipole-dipole, or steric 
interactions that are unavailable in native cyclodextrins so that one enhance the binding 
affinity and enantioselectivity. Moreover, charged cyclodextrin can be synthesized by 
replacing the hydroxyl groups with charged substituents for the purpose of separating 
oppositely charged analyte molecules. For example, positively charged amino-
cyclodextrins can be used to separate negatively charged chiral carboxyl acids.  
 
On the other hand, the challenges for the modification of native cyclodextrins are the 
presence of a large number of hydroxyl groups located at three different positions [68]. 
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As shown in Figure 6.1, the β-cyclodextrin molecule consists of numerous hydroxyl 
groups, which are located in the C2, C3 and C6 positions. It has been reported that the 
C6-OH groups at the primary rim are the most basic and nucleophilic; the C2-OH groups 
at the secondary rim are the most acidic; the C3-OH groups are the most inaccessible [69]. 
The derivatives that are used in experiments are usually randomly substituted. They are 
not homogenous; instead, they consist of a large number of isomers which differ in the 
degree of substitution as well as the position of substitution. Almost every isomer has 
different chiral recognition abilities. The degree of substitution is important in 
complexing capability of β-cyclodextrin derivatives with the guest molecules. For 
example, in the case of (2-hydroxyl)propyl-β-cyclodextrin, the higher the degree of 
hydroxypropyl substitution, the poorer was the observed drug binding [70]. Hence, the 
degree of chiral selectivity may also be affected by the degree of substitution. For 
instance, it has been reported that the retention order of enantiomers could be reversed by 
using different degrees of substitution of sulfated β-cyclodextrin [58]. Moreover, 
randomly substituted derivatives are difficult to reproduce and are unsuitable for 
mechanistic studies and method validation. However, the synthesis of single-isomeric 
substituted derivatives is quite difficult.  
 
Figure 6.1 Atom-labeling scheme for β- cyclodextrin. 
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6.2 Enhanced Selectivity by Modified Cyclodextrin 
 
In order to enhance chiral selectivity, we study the cyclodextrin derivative, Heptakis (2-
O-Acetylated)-β-cyclodextrin, which is a single-isomeric derivative with a degree of 
substitution of seven, as shown in Figure 6.2.  
 
 
Figure 6.2 Atomic structures of Heptakis (2-O-Acetylated)-β-cyclodextrin 
 
6.2.1 Complexation of Modified Cyclodextrin and Tryptophan 
 
We use Monte Carlo Simulations (details discussed in Chapter 4.1) to identify the 
possible binding site about the complexation occurred between (L- or D-) tryptophan and 
Heptakis (2-O-Acetylated)-β-cyclodextrin. In contrast to the native β-cyclodextrin, where 
only one binding configuration occurs, two different binding modes are found for the 
Heptakis (2-O-Acetylated)-β-cyclodextrin and tryptophan, named as L1-complex and L2-
complex for L-tryptophan with the chiral selector and the name of D1-complex and D2-
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complex for D-tryptophan with the chiral selector. As shown in Figure 6.3, for L1-
complex and D1-complex, the aromatic ring of tryptophan faces the primary rim; 
whereas it faces the secondary rim in the L2-complex and D2-complex.  
 
                   
                  
 
Figure 6.3 The structures of complexes of tryptophan and Heptakis (2-O-Acetylated)-β-
cyclodextrin from MC simulations. (a) L1-complex, (b) D1-complex, (c) L2-




6.2.2 Interaction Energy Calculations of the Inclusion Complex 
 
6.2.2.1 Comparison between the L-complex and D-complex 
 
As we have stated, the interaction energy of complexation is one measurement of the 
stability of the inclusion complexes formed by enantiomers and Heptakis (2-O-
Acetylated)-β-cyclodextrin. The overall interaction energy of the complex and the 
different components of the energy are shown in Table 6.1. The first column shows the 
center of mass distance (COM) between the tryptophan and the chiral selector, which 
gives indication of how closely the two molecules are packed together. It is found that for 
both inclusion modes, the COM distances for the D-complex are smaller than that for the 
L-complex (0.244 nm for the D1-complex and 0.306 nm for the L1-complex, 0.132 nm 
for the D2-complex and 0.132 for the L2-complex); correspondingly, the interaction 
energies for the D-complex are lower than those for the L-complex (−162.1 kJ/mol for 
the D1-complex and −137.9 kJ/mol for the L1-complex, −205.4 kJ/mol for the D2-
complex and −193.6 kJ/mol for the L2-complex). Hence, we conclude that D-tryptophan 
binds more strongly with the chiral selector than L-tryptophan for both the inclusion 
modes.  
 
From the analysis of the individual components of the interaction energy, it is found 
that short-range Lennard-Jones interactions are mainly responsible for the complex 
formation since they are the main constituents for the overall interaction energy; however, 
Coulombic interactions take the primary responsibility for the enantiodiscrimination 
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because the difference for the Coulomb interaction for the L-complex and D-complex 
dominates in the overall interaction energy difference.  
 
Table 6.1 Overall binding energies calculated and their individual components for the 
complexes. COM stands for Center of Mass Distance (nm). 
 
(kJ/mol) COM 
(nm) LJ-(SR) LJ-(LR) Coulomb 
Interaction 
Energy 
L1-Complex 0.306 – 113.8 – 0.3 – 23.8 – 137.9 
D1-Complex 0.244 – 109.6 – 0.3 – 52.2 – 162.1 
Difference 0.062 – 4.2 0.0 28.4 24.2 
L2-complex 0.132 – 121.4 – 0.2 – 72.0 – 193.6 
D2-complex 0.093 – 123.8 – 0.2 – 81.5 – 205.4 
Difference 0.039 2.4 0.0 9.5 11.8 
 
  
The same conclusion, namely, that D-tryptophan binds to Heptakis (2-O-Acetylated)-
β-cyclodextrin more strongly than L-tryptophan, can also be drawn from the hydrogen 
bond formation analysis as shown in Table 6.2. The average number of hydrogen bond 
formed during the simulation is larger for the D-complex compared to the number for the 
L-complex (1.81 for the D1-complex and 0.80 for the L1-complex, 2.34 for the D2-
complex and 2.29 for the L2-complex). Moreover, the number of time–frames over 
which several hydrogen bonds exist simultaneously between tryptophan and cyclodextrin 
molecules is larger for the D-complex than the L-complex. This means that D-tryptophan 
seems to form network of multiple hydrogen bonds with the chiral selector so that the 




Table 6.2 The number of hydrogen bonds (HB) between Heptakis (2-O-Acetylated)-β-
cyclodextrin and tryptophan enantiomer at equilibrium. “Single HB” 
represents the number of time frames over which only one hydrogen-bond is 
formed.  “Two HB”, “Three HB” and “Four HB” represent the number of time 
frames over which there are two, three and four hydrogen bonds formed 
simultaneously. 
 
No. of Hbond Average Single HB Two HB Three HB Four HB 
L1-Complex 0.80 4558 1264 52 0 
D1-Complex 1.81 2536 4614 76 0 
L2-complex 2.29 1775 3614 2636 783 
D2-complex 2.34 1293 3997 2727 781 
 
6.2.2.2 Comparison between the Two Inclusion Modes 
 
As already stated, there are two possible binding modes for the formation of the inclusion 
complex. One is the aromatic ring of tryptophan facing the primary rim (L1-complex and 
D1-complex); the other is the aromatic ring facing the secondary rim (L2-complex and 
D2-complex). The second inclusion mode is more stable than the first one because of the 
smaller COM distance (0.132 nm for the L2-complex and 0.306 nm for the L1-complex, 
0.093 nm for the D2-complex and 0.244 nm for the D1-complex), the lower overall 
interaction energy and the more average number of hydrogen bonds for the second 
inclusion mode. Although the second inclusion mode is more favorable, the first 
inclusion mode provides larger possibility for enantiodiscrimination since there exits a 
large difference in the overall interaction energy and average number of hydrogen bonds 
between the L-complex and the D-complex. 
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6.2.2.3 Comparison between the Native and Derivatized Cyclodextrin 
 
As we have discussed, the purpose of derivatizing native cyclodextrins is to enhance the 
binding affinity and chiral discrimination of the chiral selector for analyte enantiomers. 
For the acetylated cyclodextrin, we found that the enantioselectivity towards tryptophan 
has been enhanced compared to native cyclodextrin (∆∆E ~ 18 kJ/mol for acetylated 
cyclodextrin and ∆∆E ~ 4 kJ/mol for native cyclodextrin). In the case of the native 
cyclodextrin, short-range Lennard-Jones interactions are responsible for both the complex 
formation and chiral discrimination; however, for the acetylated cyclodextrin, it is the 
coulomb interactions that take the responsibility for enantiodiscrimination although the 
short-range Lennard-Jones interactions still play an important role in complex formation. 
Moreover, the binding affinity is reversed for the derivatized cyclodextrin since the 
native cyclodextrin prefers binding with the L-enantiomer and the acetylated cyclodextrin 




Because of the numerous hydroxyl groups situated at both the primary and secondary 
rims of native cyclodextrins, cyclodextrins can be derivatized by other functional groups 
to introduce new structure and functionality into cyclodextrins that are unavailable in the 
native form. The modification of the native cyclodextrins may enhance the binding 
affinity and chiral selectivity towards analyte molecules. However, the challenges facing 
modification are that there are so many hydroxyl groups and the production of single-
isomeric derivative form is difficult. In the present work, we studied one single-isomeric 
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derivative, Heptakis (2-O-Acetylated)-β-cyclodextrin, to investigate the effect of the 
derivatization on chiral selectivity. The results show that this derivatized form of 





CHAPTER 7 CONCLUDING REMARKS 
 
The main objective of this work is to investigate a few key fundamental issues 
concerning the mechanism of how cyclodextrins as chiral selectors bind and recognize 
the two enantiomers of chiral molecule through molecular simulations. Here, we choose 
β-cyclodextrin as the chiral selector and tryptophan as the chiral molecule.  
 
First, an initial picture of the formation of an inclusion complex by β-cyclodextrin 
and tryptophan enantiomer is obtained from Monte Carlo simulations. Then, molecular 
dynamics simulations are used to study the dynamics of the complex in a solvent as a 
function of time. Based on the overall interaction energy calculations, formation of the 
hydrogen-bonded networks and radial distribution functions, we conclude that L-
tryptophan interacts with β-cyclodextrin more strongly than D-tryptophan. Moreover, 
short-range Lennard-Jones interactions play a major role in both the complex formation 
and chiral discrimination. It is possible to enhance the enantioselectivity by introducing 
Coulomb interactions using charged cyclodextrin derivatives. In addition, the secondary 
rim of β-cyclodextrin is more responsible for the enantiorecognition because D-
tryptophan interacts with the C2 hydroxyl group on β-cyclodextrin more strongly and L-
tryptophan interacts with C3 hydroxyl group on β-cyclodextrin molecule favorably 
(Figure 2.1). Therefore, derivatizing β-cyclodextrin with functional groups at the C2 or 
C3 position may allow one to alter the selectivity towards tryptophan enantiomers. 
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Secondly, a computational model for separating racemic mixtures is established in 
order to mimic real experiments based on membrane-based separation systems in which 
the chiral selector grafted on the membrane surface acts as a chiral film to discriminate 
enantiomers. The β-cyclodextrin molecules bind the two enantiomers with different 
stability, which, in turn, results in different effective transport of the enantiomers and 
different displacement with time. The enantiomer that binds to β-cyclodextrin more 
strongly will be transported through the chiral film slower than the other enantiomer. 
Further, because of the low chiral selectivity of β-cyclodextrin, the separation efficiency 
we predict is also quite small (about 1.1), which is consistent with the experimental value 
of 1.0 reported recently by Xiao and Chung [41] and with our binding energy calculations. 
 
Lastly, we find that L-tryptophan prefers interacting with the C3 hydroxyl group and 
D-tryptophan favors the C2 hydroxyl group on native β-cyclodextrin. Therefore, 
derivatization of β-cyclodextrin at the C2 or C3 positions may allow one to change the 
selectivity. To this end, we studied a single-isomeric derivative, Heptakis (2-O-
Acetylated)-β-cyclodextrin, to investigate the effect of the derivatization on the chiral 
selectivity. The results show that this derivatized form of cyclodextrin does give better 
chiral selectivity than the native cyclodextrin. Moreover, for the derivatized cyclodextrin, 
the main discriminating forces are Coulomb interactions, in contrast to the case of the 
native cyclodextrin, where short-range Lennard-Jones interactions are responsible for the 
discrimination. In addition, the elution order for derivatized cyclodextrin is the reverse of 
the one for the native form, i.e. D-tryptophan is more tightly bound to the derivatized 
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